Colorectal Carcinoma — Trials

Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 344
Recruiting: 194
Ph III recruiting: 12
Growth YoY: +2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 101–150 of 372 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07033026	An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.	recruiting	Phase 2	136	NGM Biopharmaceuticals, IncINDUSTRY	4	Apr 1, 2026	clinicaltrials
NCT04963283	Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer	active not recruiting	Phase 2	48	University of Colorado, DenverOTHER	1	Mar 31, 2026